Kymera Therapeutics, Inc. (KYMR)
117.29
-1.34
(-1.13%)
USD |
NASDAQ |
Sep 03, 16:00
115.81
-1.48
(-1.26%)
After-Hours: 20:00
Kymera Therapeutics Cash and Short Term Investments (Quarterly) : 690.98M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 690.98M |
| March 31, 2026 | 650.93M |
| December 31, 2025 | 848.28M |
| September 30, 2025 | 505.68M |
| June 30, 2025 | 665.44M |
| March 31, 2025 | 463.15M |
| December 31, 2024 | 488.74M |
| September 30, 2024 | 549.97M |
| June 30, 2024 | 509.95M |
| March 31, 2024 | 520.54M |
| December 31, 2023 | 374.88M |
| September 30, 2023 | 357.82M |
| June 30, 2023 | 367.57M |
| March 31, 2023 | 396.88M |
| Date | Value |
|---|---|
| December 31, 2022 | 407.17M |
| September 30, 2022 | 481.91M |
| June 30, 2022 | 392.31M |
| March 31, 2022 | 420.81M |
| December 31, 2021 | 442.42M |
| September 30, 2021 | 536.39M |
| June 30, 2021 | 359.11M |
| March 31, 2021 | 333.54M |
| December 31, 2020 | 296.20M |
| September 30, 2020 | 293.84M |
| June 30, 2020 | 155.96M |
| March 31, 2020 | |
| December 31, 2019 | 91.96M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.602B |
| Oncolytics Biotech, Inc. | 4.115M |
| Sangamo Therapeutics, Inc. | 27.59M |
| Sarepta Therapeutics, Inc. | 788.49M |
| Anixa Biosciences, Inc. | 13.69M |